Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioventure is a UAE-based pharmaceutical and biotechnology company that focuses on the Middle East and Africa (MEA) markets. As a subsidiary of GlobalOne Healthcare Holding, the company specializes in technology transfer, licensing, and the commercialization of biopharmaceuticals, specialty generics, and medical devices. Bioventure maintains strategic partnerships with global leaders such as Alvotech and Biogen to bring advanced therapies, including biosimilars for autoimmune diseases and oncology, to the region. The company also invests in healthcare innovation and provides end-to-end solutions from regulatory approval to market access. Its portfolio includes high-value biosimilars targeting indications such as rheumatoid arthritis and macular degeneration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioventure View.